sábado, 11 de julio de 2009

Are some Big Pharma encouraging larger doses than needed

When a recent manufacturing problem threatened a potential Cerezyme shortage, Genzyme's response seemed to confirm some critics' long-held suspicions that the company may be encouraging inflated dosage -- and therefore higher sales -- of its drug, which costs patients hundreds of thousands of dollars a year.


No hay comentarios: